Literature DB >> 18770633

Differentiation of mouse embryonic stem cells into blood.

Yunglin D Ma1, Jesse J Lugus, Changwon Park, Kyunghee Choi.   

Abstract

Embryonic stem (ES) cells can be maintained as pluripotent stem cells or induced to differentiate into many different somatic cell types. As ES-derived somatic cells can potentially be used for cell transplantation or cell-based therapy, ES cells have gained much scientific and general public attention. Successful derivation of blood from ES cells for tissue engineering will require a comprehensive understanding of inductive signals and downstream effectors involved in blood lineage development. Ideally, directed differentiation of ES cells into blood and isolation of pure hematopoietic progenitors will enhance our ability to utilize ES-derived blood cells for future clinical applications. The protocols provided in this unit describe methods of maintaining and differentiating mouse ES cells as well as identifying and isolating hematopoietic progenitors by utilizing flow cytometry and progenitor assays.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770633      PMCID: PMC2640320          DOI: 10.1002/9780470151808.sc01f04s6

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  18 in total

1.  Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression.

Authors:  Yun Shin Chung; Wen Jie Zhang; Elizabeth Arentson; Paul D Kingsley; James Palis; Kyunghee Choi
Journal:  Development       Date:  2002-12       Impact factor: 6.868

2.  GATA2 functions at multiple steps in hemangioblast development and differentiation.

Authors:  Jesse J Lugus; Yun Shin Chung; Jason C Mills; Shin-Il Kim; Jeff Grass; Michael Kyba; Jason M Doherty; Emery H Bresnick; Kyunghee Choi
Journal:  Development       Date:  2006-12-13       Impact factor: 6.868

3.  A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells.

Authors:  Changwon Park; Iva Afrikanova; Yun Shin Chung; Wen Jie Zhang; Elizabeth Arentson; Guo hua Fong Gh; Alexander Rosendahl; Kyunghee Choi
Journal:  Development       Date:  2004-06       Impact factor: 6.868

4.  Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1.

Authors:  L Pevny; M C Simon; E Robertson; W H Klein; S F Tsai; V D'Agati; S H Orkin; F Costantini
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

5.  Hematopoietic commitment during embryonic stem cell differentiation in culture.

Authors:  G Keller; M Kennedy; T Papayannopoulou; M V Wiles
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

6.  Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.

Authors:  R A Shivdasani; E L Mayer; S H Orkin
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

7.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

8.  An early haematopoietic defect in mice lacking the transcription factor GATA-2.

Authors:  F Y Tsai; G Keller; F C Kuo; M Weiss; J Chen; M Rosenblatt; F W Alt; S H Orkin
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

9.  Generation of lymphohematopoietic cells from embryonic stem cells in culture.

Authors:  T Nakano; H Kodama; T Honjo
Journal:  Science       Date:  1994-08-19       Impact factor: 47.728

10.  Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture.

Authors:  M V Wiles; G Keller
Journal:  Development       Date:  1991-02       Impact factor: 6.868

View more
  4 in total

1.  5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation.

Authors:  Hee-Don Chae; Man-Ryul Lee; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

Review 2.  Harnessing the potential of induced pluripotent stem cells for regenerative medicine.

Authors:  Sean M Wu; Konrad Hochedlinger
Journal:  Nat Cell Biol       Date:  2011-05       Impact factor: 28.824

3.  Forming megakaryocytes from murine-induced pluripotent stem cells by the inducible overexpression of supporting factors.

Authors:  Katharina Cullmann; Magdalena Jahn; Markus Spindler; Franziska Schenk; Georgi Manukjan; Adele Mucci; Doris Steinemann; Klaus Boller; Harald Schulze; Markus Bender; Thomas Moritz; Ute Modlich
Journal:  Res Pract Thromb Haemost       Date:  2020-12-03

4.  Murine iPSC-Derived Macrophages as a Tool for Disease Modeling of Hereditary Pulmonary Alveolar Proteinosis due to Csf2rb Deficiency.

Authors:  Adele Mucci; Jessica Kunkiel; Takuji Suzuki; Sebastian Brennig; Silke Glage; Mark P Kühnel; Mania Ackermann; Christine Happle; Alexandra Kuhn; Axel Schambach; Bruce C Trapnell; Gesine Hansen; Thomas Moritz; Nico Lachmann
Journal:  Stem Cell Reports       Date:  2016-07-21       Impact factor: 7.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.